Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Altrazeal Life Sciences Inc.
| Metric | Altrazeal Life Sciences Inc. Healthcare |
|---|---|
| Quality Score | 48 / 100 |
| Revenue (latest) | $717,157 |
| Net income (latest) | −$2M |
| Operating margin | −242.3% |
| Net margin | −270.0% |
| Return on equity | −31.7% |
| Return on assets | −22.7% |
| Return on capital (ROCE) | −24.7% |
| Debt / equity | 0.40× |
| Revenue growth (YoY) | 62.0% |
| Altman Z″ (distress) | -20.24 |
| Accruals / assets | 3.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.